scispace - formally typeset
S

Silvana Maria Alban

Researcher at Federal University of Paraná

Publications -  11
Citations -  134

Silvana Maria Alban is an academic researcher from Federal University of Paraná. The author has contributed to research in topics: Phage display & Antigen. The author has an hindex of 6, co-authored 10 publications receiving 112 citations.

Papers
More filters
Journal ArticleDOI

Comparison of conventional serology and PCR methods for the routine diagnosis of Trypanosoma cruzi infection.

TL;DR: This work aimed to compare the current diagnostic methods for Chagas disease, including conventional serological and ELISA and molecular techniques (PCR), to introduce PCR as an auxiliary technique.
Journal ArticleDOI

Phage display and synthetic peptides as promising biotechnological tools for the serological diagnosis of leprosy.

TL;DR: Evidence is revealed in support of phage-displayed peptides as promising biotechnological tools for the design of leprosy diagnostic serological assays and their potentials as diagnostic reagents must be more extensively evaluated in future studies.
Journal ArticleDOI

Identification of mimotopes of Mycobacterium leprae as potential diagnostic reagents

TL;DR: The preliminary data suggest that it may be possible to develop reagents with diagnostic potential based on peptide mimotopes selected by phage display using polyclonal human antibodies.
Journal ArticleDOI

Association of antibodies against Neospora caninum in mares with reproductive problems and presence of seropositive dogs as a risk factor.

TL;DR: The presence of seropositive dogs as a risk factor for N. caninum in mares suggests the necessity for further investigation of the epidemiology of this parasite in horse-breeding farms with reproductive problems and the presence of cattle and dogs.
Journal ArticleDOI

Synthetic Peptides as Potential Antigens for Cutaneous Leishmaniosis Diagnosis.

TL;DR: Results show a new route for discovering molecules for diagnosis or for immunoprotection against leishmaniosis, and the peptides' MIX showed the best performance, followed by the P1 (72% sensitivity), and the AS presented 91% sensitivity.